Paul Kostenuik, PhD, is an Adjunct Professor at the University Of Michigan School Of Dentistry. Dr. Kostenuik is also the CEO, President, and co-founder of Ortheus Inc., a biotherapeutics company focused on the development of novel tissue regeneration approaches.
He is also the owner and founder of Phylon Pharma Services, a company providing R&D consulting as well as regulatory, scientific, medical communications, and medical writing support to the pharmaceutical, biotechnology, and medical device industries.
After a PhD in Medical Sciences at McMaster University and post-doctoral fellowships in La Jolla and at UC San Francisco, Dr. Kostenuik joined the Orthopedic Surgery faculty at Boston University. Dr. Kostenuik then worked for 16 years as Scientific Director at Amgen Inc. where he led research teams engaged in the discovery, validation and development of novel therapeutics for musculoskeletal, oncologic, renal, dental, rheumatologic, pediatric, metabolic and orthopedic indications. He is an inventor on several patents and an author on over 100 peer-reviewed journal articles and several book chapters.